EUVIMEDEUVIMED entdecken
Open Access

A bioengineered lymphatic vessel model for studying lymphatic endothelial cell‐cell junction and barrier function

Aria R Henderson, Isabelle S Ilan, Esak Lee

Microcirculation · 2021-11 · 28 (8)

DOI: 10.1111/micc.12730 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microcirculation, online erschienen am 04.10.2021. Verfasst von Aria R Henderson und 2 weiteren Autor:innen. Beteiligte Einrichtung: Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York, USA. Hauptthemen laut MEDLINE: Lymphatic Vessels, Lymphedema. Die Arbeit wurde bisher 59-mal zitiert (Crossref) und nennt 83 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Lymphatic vessels (LVs) maintain fluid homeostasis by draining interstitial fluid. A failure in lymphatic drainage triggers lymphatic diseases such as lymphedema. Since lymphatic drainage is regulated by lymphatic barrier function, developing experimental models that assess lymphatic barrier function is critical for better understanding of lymphatic physiology and disease.

Methods

We built a lymphatic vessel‐on‐chip (LV‐on‐chip) by fabricating a microfluidic device that includes a hollow microchannel embedded in three‐dimensional (3D) hydrogel. Employing luminal flow in the microchannel, human lymphatic endothelial cells (LECs) seeded in the microchannel formed an engineered LV exhibiting 3D conduit structure.

Results

Lymphatic endothelial cells formed relatively permeable junctions in 3D collagen 1. However, adding fibronectin to the collagen 1 apparently tightened LEC junctions. We tested lymphatic barrier function by introducing dextran into LV lumens. While LECs in collagen 1 showed permeable barriers, LECs in fibronectin/collagen 1 showed reduced permeability, which was reversed by integrin α5 inhibition. Mechanistically, LECs expressed inactivated integrin α5 in collagen 1. However, integrin α5 is activated in fibronectin and enhances barrier function. Integrin α5 activation itself also tightened LEC junctions in the absence of fibronectin.

Conclusions

Lymphatic vessel‐on‐chip reveals integrin α5 as a regulator of lymphatic barrier function and provides a platform for studying lymphatic barrier function in various conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphatic VesselsLymphedemaEndothelial CellsEndothelium, LymphaticHumansIntercellular Junctions

Stichwörter der Autor:innen

3D bioengineered modelsLV-on-chipintegrin α5junctionslymphatic barrier functionlymphatic endothelial cells

Autor:innen und Institutionen

  • Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York, USA.
  • College of Human Ecology, Cornell University, Ithaca, New York, USA.

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS

Zitieren

APA

Henderson, A. R., Ilan, I. S., & Lee, E. (2021). A bioengineered lymphatic vessel model for studying lymphatic endothelial cell‐cell junction and barrier function. Microcirculation, 28(8). https://doi.org/10.1111/micc.12730

Vancouver

Henderson AR, Ilan IS, Lee E. A bioengineered lymphatic vessel model for studying lymphatic endothelial cell‐cell junction and barrier function. Microcirculation. 2021;28(8). doi:10.1111/micc.12730

BibTeX
@article{Henderson2021,
  author = {Henderson, Aria R and Ilan, Isabelle S and Lee, Esak},
  title = {A bioengineered lymphatic vessel model for studying lymphatic endothelial cell‐cell junction and barrier function},
  journal = {Microcirculation},
  year = {2021},
  volume = {28},
  number = {8},
  doi = {10.1111/micc.12730}
}
Kostenlos starten →